Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
- Largest single sale: $762K (1,557 shares) of Vertex Pharmaceuticals on Feb 17, 2026. Filing
- Last sale before this period: Feb 25, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Vertex Pharmaceuticals (VRTX) | SVP & Chief Accounting Officer | May 3, 2021 | Sep 1, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 28, 2026, Vertex Pharmaceuticals: 5,000 shares granted. 1 filing: 1
- Feb 26, 2026, Vertex Pharmaceuticals: sold 357 shares for $173K, under a disclosed plan. 1 filing: 1
- Feb 25, 2026, Vertex Pharmaceuticals: sold 223 shares for $108K, under a disclosed plan. 1 filing: 1
- Feb 24, 2026, Vertex Pharmaceuticals: 546 shares withheld by the company for taxes. 1 filing: 1
- Feb 18, 2026, Vertex Pharmaceuticals: sold 638 shares for $302K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.